NeuroVive Pharmaceutical AB EV/EBITDA
Qual é o EV/EBITDA de NeuroVive Pharmaceutical AB?
O EV/EBITDA de NeuroVive Pharmaceutical AB é N/A
Qual é a definição de EV/EBITDA?
EV/EBITDA é o valor da empresa dividido pelo lucro antes de juros, impostos, depreciação e amortização. É uma medida de quão cara é uma ação e é mais frequentemente válida para comparações entre empresas do que da relação entre preço e lucro. Ele mede o preço (na forma de valor da empresa) que um investidor paga em benefício do fluxo de caixa da empresa (na forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de empresas na Setor Health Care em OTC em comparação com NeuroVive Pharmaceutical AB
O que NeuroVive Pharmaceutical AB faz?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Empresas com ev/ebitda semelhantes a NeuroVive Pharmaceutical AB
- Long Blockchain tem EV/EBITDA de N/A
- Long Blockchain tem EV/EBITDA de N/A
- Allot Ltd tem EV/EBITDA de N/A
- Seneca Biopharma Inc tem EV/EBITDA de N/A
- Cantex Mine Development tem EV/EBITDA de N/A
- Rockwealth Resources tem EV/EBITDA de N/A
- NeuroVive Pharmaceutical AB tem EV/EBITDA de N/A
- SandRidge Permian Trust tem EV/EBITDA de N/A
- NetMed tem EV/EBITDA de N/A
- Tongda Hong Tai tem EV/EBITDA de N/A
- Aspire Mining tem EV/EBITDA de N/A
- Linius Technologies tem EV/EBITDA de N/A
- Cloud DX tem EV/EBITDA de N/A